Accessibility Menu
Medican Enterprises logo

Medican Enterprises(OTC) MDCN

Market Cap$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1991)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Medican Enterprises last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-30
Medican Enterprises stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-22
1 month+0%USD 0.002026-06-30
3 month+0%USD 0.002026-05-01
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-29
3 year+0%USD 0.002023-07-28
5 year-99.8%USD 0.002021-07-30
Since inception-100%USD 5.181991-09-16

Medican Enterprises Financials at a Glance

Market Cap

$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.60M

Net Income (TTM)

$4.65M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-29.29 (Low)

Price

$0.00

Volume

1,000,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

MDCN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medican Enterprises

Medican Enterprises, Inc. is a bio-pharmaceutical company focused on the production, cultivation, and wholesale distribution of cannabis-related products. Established in 1988 and headquartered in Los Angeles, California, the company operates within the medical and pharmaceutical industry.

Products and Services
  • Wholesale distribution of cannabis-related products
  • Research and development in bio-pharmaceuticals
  • Consultation services for cannabis cultivation
Growth Outlook
  • Recent quarterly revenue reached $936,872, indicating potential for growth
  • Operating income for Q1 2025 was $789,425, showcasing operational efficiency
  • Strategic positioning in the expanding cannabis market supports future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of $936,872 reflects recent operational success
  • Net income for Q1 2025 was $789,425, demonstrating profitability
  • Market capitalization stands at approximately $2.88 million, indicating growth potential
Medican Enterprises, Inc. is positioned in a rapidly evolving sector, with a focus on cannabis-related products that are gaining traction in the healthcare market. The recent quarterly performance highlights a significant revenue increase, suggesting a positive trend in operational capabilities. The company's strategic initiatives in research and development, alongside its established distribution network, provide a solid foundation for future growth. Investors may find the company's focus on the expanding cannabis market appealing, as it aligns with broader trends in healthcare and wellness.
AI Generated • Jul 29, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Mitchell Xavier

Website

www.medicaninc.com

Headquarters

Los Angeles, CA 91367, US

MDCN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-5.20%

Return on Capital

-4.15%

Return on Assets

-2.51%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

46.55B

Volume

1.00M

Avg. Volume

1.39M

Financials (TTM)

Gross Profit

$342.33K

Operating Income

-$927.10K

EBITDA

$1.65M

Operating Cash Flow

-$9.39M

Capital Expenditure

-$5.00

Free Cash Flow

-$9.39M

Cash & ST Invst.

$75.30K

Total Debt

$19.82M

Medican Enterprises Performance Analysis

Medican Enterprises annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 4,239,220N/A
20222022-12-31USD 2,608,851-38.5%
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
Medican Enterprises sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-23.6%
Q22024-06-30N/A
Q42024-12-31N/A
Q12025-03-31N/A
Medican Enterprises annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.00N/A
20222022-12-31USD 0.00N/A
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
Medican Enterprises sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-304899.5%
Q22024-06-30N/A
Q42024-12-31N/A
Q12025-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$936.87K

+7.7%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$15.50K

N/A

Employees

3

N/A

Net Income

$789.43K

+913.4%

EBITDA

$789.43K

+400.0%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

$75.30K

-74.1%

Total Debt

$19.82M

-22.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$19.82M

-22.8%

Short Term Debt

$0.00

N/A

Return on Assets

-2.51%

N/A

Return on Invested Capital

-4.15%

N/A

Free Cash Flow

-$19.35M

-28040.3%

Operating Cash Flow

-$19.35M

-28040.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRDVCommunity Redevelopment Inc.
$0.00+0.00%
BRSTBroad Street Realty, Inc.
$0.00+0.00%
CDJMCarnegie Development, Inc.
$0.00+0.00%
FUTLFutureLand, Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About MDCN

What is the current price of Medican Enterprises?

Medican Enterprises is trading at $0.00 per share.

What is the 52-week range for Medican Enterprises?

Over the past 52 weeks, Medican Enterprises has traded between $0.00 and $0.00.

How much debt does Medican Enterprises have?

As of the most recent reporting period, Medican Enterprises reported total debt of $16.48M.

How much cash does Medican Enterprises have on hand?

Medican Enterprises reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Medican Enterprises’s dividend yield?

Medican Enterprises does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services